SERUM LEVELS OF INSULIN‐LIKE GROWTH FACTOR BINDING PROTEIN‐3 IN BENIGN AND MALIGNANT BREAST DISEASE

Abstract

Either the production or clearance of IGFBP-3 is altered in benign breast disease so that there is less free IGF available to cells. This may serve to protect against malignant transformation in patients with benign breast disorders.